Immunovant
IMVT
#2555
Rank
A$10.22 B
Marketcap
A$49.42
Share price
-0.12%
Change (1 day)
35.79%
Change (1 year)

Market capitalization of Immunovant (IMVT)

Market cap: A$10.22 Billion

As of November 2026 Immunovant has a market cap of A$10.22 Billion. This makes Immunovant the world's 2555th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Immunovant from 2019 to 2026

End of year Market Cap

Year Marketcap Change
2026A$10.22 B29.97%
2025A$7.86 B36.16%
2024A$5.77 B-35.39%
2023A$8.94 B165.48%
2022A$3.36 B149.32%
2021A$1.35 B-77.02%
2020A$5.88 B374.66%
2019A$1.23 B

End of Day market cap according to different sources

On Nov 18th, 2026 the market cap of Immunovant was reported to be:

A$10.22 Billion
by Nasdaq info icon info icon
A$10.22 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
ORIC Pharmaceuticals
ORIC
A$1.18 B-88.42%๐Ÿ‡บ๐Ÿ‡ธ USA